Blog
New FDA Guidance Aims to Simplify the Biosimilar Approval Process
In a new draft guidance, issued on October 29, 2025, the FDA proposed major updates to simplify biosimilarity studies and potentially reduce clinical testing for therapeutic protein products….
By: Goodwin